Altor BioScience
VerifiedResearches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$45—68m (Dealroom.co estimates Jul 2012.)
Miramar Florida (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
$290m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Recent News about Altor BioScience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.